Top Wealth Group Holding Ltd TWG
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS3.87
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $9.1M | $4.7M | $16.9M | $3.1M | $19.6K | — |
| Cost of revenue | $2.3M | $2.2M | $11.6M | $4.3M | $4.3K | — |
| Gross profit | $6.8M | $2.5M | $5.4M | $4.2M | $15.3K | — |
| SG&A | $1.2M | $1.6M | $1.8M | $466.5K | $21.0K | — |
| Pre-tax income | $3.2M | -$2.0M | $3.0M | $2.3M | -$16.9K | — |
| Income tax | — | — | $607.2K | $362.6K | $5.9K | — |
| Net income | $3.2M | -$2.0M | $2.4M | $1.9M | -$11.0K | — |
| EPS, basic | 4.35 | -5.31 | 8.13 | 0.07 | -0.00 | — |
| EPS, diluted | 3.87 | -5.31 | 8.13 | 0.07 | -0.00 | — |
| Shares, diluted (wtd. avg.) | 823,793 | 380,419 | 300,000 | 27.0M | 27.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $2.4M | $42.4K | $134.3K | $217.4K | $1.4K | $581 |
| Receivables | $9.2M | $1.6M | $6.0M | $33.4K | — | — |
| Inventory | $3.5M | — | $153.2K | $2.1M | — | — |
| Total current assets | $17.4M | $3.8M | $7.1M | $3.0M | — | — |
| Property, plant and equipment | $72.7K | $72.7K | $134.5K | $368.2K | — | — |
| Total assets | $29.4M | $19.8M | $7.3M | $3.4M | — | — |
| Accounts payable | $472.3K | — | — | $200.6K | — | — |
| Short-term debt | $147.2K | — | $777.9K | — | — | — |
| Total current liabilities | $1.6M | $1.2M | $2.4M | $902.6K | — | — |
| Total liabilities | $1.7M | $1.2M | $2.4M | $920.3K | — | — |
| Retained earnings | $5.5M | $2.3M | $4.3M | $1.9M | — | — |
| Total equity | $27.8M | $18.6M | $5.0M | $2.5M | -$46.9K | -$35.9K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$6.2M | $887.6K | -$863.6K | $120.3K | $63.5K | — |
| Depreciation and amortisation | — | $61.9K | $233.7K | $173.2K | $2.5K | — |
| Stock-based compensation | $1.7M | — | — | — | — | — |
| Capital expenditure | — | — | — | $481.2K | $62.7K | — |
| Investing cash flow | $4.1M | -$15.9M | — | -$481.2K | -$62.7K | — |
| Financing cash flow | $4.4M | $14.9M | $780.6K | $576.9K | $12 | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-057962.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $19.6K | $3.1M | $16.9M | $4.7M | $9.1M |
| Gross profit | — | $15.3K | $4.2M | $5.4M | $2.5M | $6.8M |
| Net income | — | -$11.0K | $1.9M | $2.4M | -$2.0M | $3.2M |
Others in SIC 2090
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MKC | MCCORMICK & CO INC | $12.95B | 16.4x | 1.7% |
| UTZ | Utz Brands, Inc. | $1.26B | 1,428.0x | 2.1% |
| MED | MEDIFAST INC | $132.7M | — | -36.0% |
| JVA | COFFEE HOLDING CO INC | $25.6M | 17.9x | 22.6% |